Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases: Pooled Analysis of Placebo Arms of Infliximab Clinical Trials

Citation:

Singh S, Proudfoot J, Xu R, et al. Inflamm Bowel Dis. 2018 Sep 15;24(10):2278-2284. Erratum in: Inflamm Bowel Dis. 2019 Sep 18;25(10):e134. PMID: 29788260; PMCID: PMC6140448.